PortfoliosLab logoPortfoliosLab logo
KLAC vs. JNJ
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

KLAC vs. JNJ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in KLA Corporation (KLAC) and Johnson & Johnson (JNJ). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, KLAC achieves a 71.29% return, which is significantly higher than JNJ's 21.57% return. Over the past 10 years, KLAC has outperformed JNJ with an annualized return of 41.50%, while JNJ has yielded a comparatively lower 10.10% annualized return.


KLAC

1D
-2.42%
1M
-20.02%
6M
32.75%
YTD
71.29%
1Y
124.39%
3Y*
66.84%
5Y*
47.12%
10Y*
41.50%
ALL TIME*
22.94%

JNJ

1D
-1.67%
1M
8.95%
6M
15.06%
YTD
21.57%
1Y
55.80%
3Y*
16.86%
5Y*
11.06%
10Y*
10.10%
ALL TIME*
12.23%
*Multi-year figures are annualized to reflect compound growth (CAGR)

KLAC vs. JNJ - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
KLAC
KLA Corporation
71.29%94.48%9.36%56.05%-11.20%68.05%47.94%103.99%-12.49%36.80%
JNJ
Johnson & Johnson
21.57%47.48%-4.81%-8.58%5.97%11.44%10.82%16.22%-5.13%24.43%

Correlation

The correlation between KLAC and JNJ is -0.12, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.12

Correlation (3Y)
Calculated over the trailing 3-year period

-0.08

Correlation (5Y)
Calculated over the trailing 5-year period

0.01

Correlation (10Y)
Calculated over the trailing 10-year period

0.13

Correlation (All Time)
Calculated using the full available price history since Mar 26, 1990

0.16

The correlation between KLAC and JNJ shifts across timeframes, from -0.12 (1 year) to 0.16 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

KLAC:

$271.18B

JNJ:

$598.96B

EPS

KLAC:

$35.32

JNJ:

$8.63

PE Ratio

KLAC:

5.88

JNJ:

28.83

PEG Ratio

KLAC:

0.22

JNJ:

0.96

PS Ratio

KLAC:

2.10

JNJ:

6.29

PB Ratio

KLAC:

4.70

JNJ:

7.49

Total Revenue (TTM)

KLAC:

$13.10B

JNJ:

$96.36B

Gross Profit (TTM)

KLAC:

$8.09B

JNJ:

$66.60B

EBITDA (TTM)

KLAC:

$5.77B

JNJ:

$31.62B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

KLAC vs. JNJ — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

KLAC
KLAC Risk / Return Rank: 9191
Overall Rank
KLAC Sharpe Ratio Rank: 9393
Sharpe Ratio Rank
KLAC Sortino Ratio Rank: 8787
Sortino Ratio Rank
KLAC Omega Ratio Rank: 8989
Omega Ratio Rank
KLAC Calmar Ratio Rank: 9292
Calmar Ratio Rank
KLAC Martin Ratio Rank: 9494
Martin Ratio Rank

JNJ
JNJ Risk / Return Rank: 9696
Overall Rank
JNJ Sharpe Ratio Rank: 9797
Sharpe Ratio Rank
JNJ Sortino Ratio Rank: 9898
Sortino Ratio Rank
JNJ Omega Ratio Rank: 9696
Omega Ratio Rank
JNJ Calmar Ratio Rank: 9595
Calmar Ratio Rank
JNJ Martin Ratio Rank: 9595
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

KLAC vs. JNJ - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for KLA Corporation (KLAC) and Johnson & Johnson (JNJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


KLACJNJDifference
Sharpe ratioReturn per unit of total volatility

-0.94

Sortino ratioReturn per unit of downside risk

-1.79

Omega ratioGain probability vs. loss probability

1.35

1.53

-0.18

Calmar ratioReturn relative to maximum drawdown

4.01

5.12

-1.11

Martin ratioReturn relative to average drawdown

13.67

14.40

-0.73

KLAC vs. JNJ - Sharpe Ratio Comparison

The current KLAC Sharpe Ratio is 2.17, which is lower than the JNJ Sharpe Ratio of 3.11. The chart below compares the historical Sharpe Ratios of KLAC and JNJ, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

KLAC vs. JNJ - Drawdown Comparison

The maximum KLAC drawdown since its inception was -83.74%, which is greater than JNJ's maximum drawdown of -50.67%. Use the drawdown chart below to compare losses from any high point for KLAC and JNJ.


Loading charts...

Drawdown Indicators


KLACJNJDifference

Max Drawdown

Largest peak-to-trough decline

-83.74%

-50.67%

-33.07%

Max Drawdown (1Y)

Largest decline over 1 year

-31.19%

-10.96%

-20.23%

Max Drawdown (3Y)

Largest decline over 3 years

-34.95%

-15.95%

-19.00%

Max Drawdown (5Y)

Largest decline over 5 years

-40.28%

-18.41%

-21.87%

Max Drawdown (10Y)

Largest decline over 10 years

-40.28%

-27.37%

-12.91%

Current Drawdown

Current decline from peak

-31.19%

-6.89%

-24.30%

Average Drawdown

Average peak-to-trough decline

-29.28%

-11.88%

-17.40%

Ulcer Index

Depth and duration of drawdowns from previous peaks

9.14%

3.89%

+5.25%

Volatility

KLAC vs. JNJ - Volatility Comparison

KLA Corporation (KLAC) has a higher volatility of 30.24% compared to Johnson & Johnson (JNJ) at 9.47%. This indicates that KLAC's price experiences larger fluctuations and is considered to be riskier than JNJ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


KLACJNJDifference

Volatility (1M)

Calculated over the trailing 1-month period

30.24%

9.47%

+20.77%

Volatility (6M)

Calculated over the trailing 6-month period

49.98%

14.38%

+35.60%

Volatility (1Y)

Calculated over the trailing 1-year period

57.81%

18.08%

+39.73%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

45.80%

17.34%

+28.46%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

42.94%

18.70%

+24.24%

Dividends

KLAC vs. JNJ - Dividend Comparison

KLAC's dividend yield for the trailing twelve months is around 0.39%, less than JNJ's 2.11% yield.


PositionTTM20252024202320222021202020192018201720162015
JNJ
Johnson & Johnson
2.11%2.48%3.40%3.00%2.52%2.45%2.53%2.57%2.74%2.38%2.73%2.87%
KLAC
KLA Corporation
0.39%0.61%0.96%0.92%1.25%0.91%1.35%1.74%3.17%2.15%2.67%2.94%

Financials

KLAC vs. JNJ - Financials Comparison

This section allows you to compare key financial metrics between KLA Corporation and Johnson & Johnson. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20.00B25.00BJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
3.42B
24.06B
(KLAC) Total Revenue
(JNJ) Total Revenue
Values in USD except per share items

KLAC vs. JNJ - Profitability Comparison

The chart below illustrates the profitability comparison between KLA Corporation and Johnson & Johnson over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

58.0%60.0%62.0%64.0%66.0%68.0%70.0%72.0%JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
61.1%
71.5%
Portfolio components
KLAC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, KLA Corporation reported a gross profit of 2.09B and revenue of 3.42B. Therefore, the gross margin over that period was 61.1%.

JNJ - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Johnson & Johnson reported a gross profit of 17.20B and revenue of 24.06B. Therefore, the gross margin over that period was 71.5%.

KLAC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, KLA Corporation reported an operating income of 1.41B and revenue of 3.42B, resulting in an operating margin of 41.2%.

JNJ - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Johnson & Johnson reported an operating income of 6.40B and revenue of 24.06B, resulting in an operating margin of 26.6%.

KLAC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, KLA Corporation reported a net income of 1.20B and revenue of 3.42B, resulting in a net margin of 35.2%.

JNJ - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Johnson & Johnson reported a net income of 5.24B and revenue of 24.06B, resulting in a net margin of 21.8%.


Frequently Asked Questions


KLAC and JNJ have a correlation of -0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

KLAC has higher volatility (30.24%) compared to JNJ (9.47%). In terms of maximum drawdown, KLAC dropped -83.74% vs JNJ's -50.67%.

JNJ currently has the higher Sharpe Ratio (3.11 vs 2.17), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for KLAC and JNJ

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer